0317 0647241

WhatsApp & Call 24/7

CinnoRA Injection (Adalimumab) 40mg/0.8ml Price in Pakistan | Impo Medic

₨ 32,500

Description

CinnoRA Injection (Adalimumab) 40mg/0.8ml Price in Pakistan

CinnoRA Injection (Adalimumab) 40mg/0.8ml is a prescription biologic medicine used to treat certain autoimmune and inflammatory conditions. It contains Adalimumab, a monoclonal antibody that targets tumour necrosis factor-alpha (TNF-α), a protein involved in inflammation. By blocking TNF-α, Adalimumab helps reduce inflammation and control symptoms associated with autoimmune diseases.

CinnoRA is an Adalimumab 40mg/0.8ml injection supplied as a pre-filled injection presentation. The exact manufacturer, country of origin, pack configuration and storage instructions should be confirmed from the specific product packaging, as these details can vary by market and presentation.

CinnoRA is manufactured by CinnaGen Co., Iran. The 40mg/0.8ml presentation is available in pre-filled injection formats; the pack configuration should be checked on the supplied carton.

pmc.ncbi.nlm.nih.gov+2

Uses of Adalimumab

Adalimumab is used to manage several autoimmune and inflammatory conditions, including:

  • Rheumatoid arthritis: Helps reduce joint inflammation, pain and swelling.

  • Psoriatic arthritis: Helps control joint symptoms and inflammation associated with psoriasis.

  • Ankylosing spondylitis: Helps reduce inflammation and stiffness in the spine.

  • Plaque psoriasis: Helps manage moderate to severe skin symptoms.

  • Crohn’s disease: Used to control inflammation in the digestive tract.

  • Ulcerative colitis: Helps manage inflammation of the colon in eligible patients.

  • Hidradenitis suppurativa: May be prescribed for certain moderate to severe cases.

The specific approved uses can vary by country and product labelling.

pmc.ncbi.nlm.nih.gov+1

How Adalimumab Works

Adalimumab is a TNF-alpha inhibitor. TNF-alpha is a protein that plays an important role in the body’s inflammatory response. In some autoimmune conditions, excessive TNF-alpha activity contributes to inflammation and tissue damage.

Adalimumab binds to TNF-alpha and blocks its activity. This helps reduce inflammation, swelling and other symptoms associated with autoimmune diseases.

Dosage and Administration

CinnoRA Injection is administered by subcutaneous injection, meaning it is injected under the skin. The recommended dose and frequency depend on the patient’s condition, age, medical history and response to treatment.

For many adult indications, 40mg every other week is a commonly used maintenance schedule, but some conditions require a different starting or maintenance regimen. The dose must be determined by a qualified healthcare professional.

  • Use only as prescribed by your doctor.

  • Follow the instructions supplied with the injection.

  • Do not change the dose or injection schedule yourself.

  • Do not use the injection if the packaging is damaged or the solution appears abnormal.

  • Follow the product-specific instructions for injection technique and storage.

Precautions

Before starting CinnoRA Injection, inform your doctor about any existing medical conditions, infections or medicines you are taking.

  • Infections: Adalimumab can increase the risk of serious infections, including tuberculosis. Screening for TB is generally required before treatment.

  • Hepatitis B: Patients with current or previous hepatitis B infection may require special assessment and monitoring.

  • Immune system: The medicine affects immune-system activity and may increase susceptibility to infections.

  • Vaccinations: Avoid live vaccines during treatment unless your specialist specifically advises otherwise.

  • Other medicines: Inform your doctor about other biologic medicines and immunosuppressants.

  • Pregnancy and breastfeeding: Discuss potential risks and benefits with your healthcare professional.

  • Storage: Follow the storage conditions printed on the supplied pack and leaflet. Do not freeze the injection.

Possible side effects include injection-site reactions, headache, rash and upper respiratory infections. Seek urgent medical attention for signs of a serious infection, allergic reaction or other severe symptoms.

Product Information

  • Brand Name: CinnoRA

  • Generic Name: Adalimumab

  • Strength: 40mg/0.8ml

  • Dosage Form: Injection

  • Route of Administration: Subcutaneous

  • Manufacturer: CinnaGen Co.

  • Country of Origin: Iran

  • Pack Size: Check the supplied product packaging; pre-filled syringe presentations are available.

FAQs about CinnoRA Injection (Adalimumab) 40mg/0.8ml Price in Pakistan

1. What is CinnoRA Injection used for?

CinnoRA contains Adalimumab and is used to treat certain autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriasis, Crohn’s disease and other eligible conditions.

2. What is the strength of CinnoRA Injection?

Each 0.8ml injection contains 40mg of Adalimumab.

3. Who manufactures CinnoRA Injection?

CinnoRA is manufactured by CinnaGen Co., based in Iran.

4. How is CinnoRA Injection administered?

It is administered under the skin (subcutaneously), following the instructions provided by the healthcare professional.

5. Does CinnoRA require a prescription?

Yes. CinnoRA is a prescription biologic medicine and should be used under specialist medical supervision.

CinnoRA Injection in Pakistan

Impo Medic provides access to specialty and imported medicines, including biologic treatments such as CinnoRA Injection (Adalimumab) 40mg/0.8ml. Contact Impo Medic to confirm current availability, pack details and CinnoRA Injection price in Pakistan. Always use this medicine with a valid prescription and guidance from your treating specialist.

Reviews

There are no reviews yet.

Be the first to review “CinnoRA Injection (Adalimumab) 40mg/0.8ml Price in Pakistan | Impo Medic”

Your email address will not be published. Required fields are marked *